Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SMART4MD

Financiado

Cerrado

Support Monitoring and Reminder Technology for Mild Dementia

As Europe’s population is ageing, long-term care for elderly citizens will become an increasing cost for society. To manage this transition healthcare policies in the EU and individual Member States are heavily focussed on extendi... ver más

30/11/2019

Anglia Ruskin Univ...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

ANGLIA RUSKIN UNIVERSITY HIGHER EDUCATION COR... No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 12 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-11-30

PHC-20-2014: Advancing active and healthy ageing...

I+D

Cerrada hace 10 años

0% 95% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

12 Participantes

Anglia Ruskin University

537.27K€ | Lider

BTH

902.58K€ | Participante

HEALTHBIT

291.79K€ | Participante

CONSORCI SANITARI DE TERRASS...

358.50K€ | Participante

Proyectos interesantes

CAREGIVERSPRO-MMD

Medical Technol...

Software

4M€ Cerrado

PREVENTIVE HEALTH SUITE DE APLICACIONES DE E...

Medical Technol...

Software

599K€ Cerrado

ehcoBUTLER

Medical Technol...

Software

4M€ Cerrado

DECI

Medical Technol...

Data Science

3M€ Cerrado

PID2019-105470RB-C32

Medical Technol...

Data Science

74K€ Cerrado

ALFRED

Medical Technol...

Software

4M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 56 meses Fecha Inicio: 2015-03-26
Fecha Fin: 2019-11-30

Líder del proyecto

ANGLIA RUSKIN UNIVERSITY HIGHER EDUCATION COR... No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto As Europe’s population is ageing, long-term care for elderly citizens will become an increasing cost for society. To manage this transition healthcare policies in the EU and individual Member States are heavily focussed on extending the independent life of the elderly, with the dual aim of increasing their quality of life and reducing the costs of care. Dementia affects more than 6% of people aged 60+ and has a devastating effect on their independence – to date, there is no proven intervention to help dementia patients live a fulfilling life for longer. In this project we will build on an innovative patient support tool to develop a mHealth application that is specifically targeted to patients with mild dementia. The tool will help patients to adhere to their treatment and share data with their carers and doctors; carers will use the same application to monitor patients more easily and share their own well-being with doctors. This will slow the patients’ cognitive and functional decline, avoid carers getting exhausted and reduce costs of emergency care. Our project will comprise two phases: first we will use digital accessibility tools to re-design the existing application for dementia patients. The development will be steered by patients, carers and doctors, through user-centric design: we will collect feedback on each new version of the application until the design is perfectly adapted to the users’ needs. In the second phase we will pilot the optimised application with 1,100 users (patients + carers) and 1,100 controls. This will show the clinical and social benefits for patients and carers, as well as financial benefits for the healthcare system. Successful delivery of the pilot will increase patients’ adherence to treatment (10 %-points), while improving the quality of life of carers and patients. It will save healthcare providers €1,818 / patient / year in care costs and will generate revenue of over €18 million / year for the consortium (Year 5).

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores